General

The week of October 10, 2013, the periodical Diabetologia published the surprising results of a study recently completed in the field of type 1 diabetes research. Once released, it quickly made headlines around the world. The noteworthy research was conducted by a series of professionals affiliated with the National Institute for Health Research Exeter Clinical Research Facility. It is located at the University of Exeter Medical School in the United Kingdom. One of the lead researchers involved with the study was Dr. Richard A. Oram. The venerable Dr. Oram and his cohorts studied 74 participants in the hopes of obtaining additional information on C-peptides and insulin production in type 1 diabetics. They tested the subjects using ultrasensitive assays over a period of several years. What they uncovered as a result of that testing was quite stunning. They determined that contrary to long held beliefs, type 1 diabetics’ bodies do continue to produce insulin via beta cells. However, those insulin levels…
On September 27, 2013, national headlines were filled with news about a recent advancement in the treatment of diabetes. It was an advancement that those in the healthcare industry have been fervently working on for years. The diabetes treatment making all of the recent headlines is Medtronic’s APDS, also known as the MiniMed530G. It is an artificial pancreas device system that the company finally received partial U.S. FDA approval on in September. The approval enables the system to be used with adult populations. The company is hoping to expand upon that approval in the future to include juveniles under the age of 16. At this point, the product itself is anticipated to be available for purchase in the coming weeks. The company’s new system consists of a CGM integrated insulin pump that has been outfitted with a hypersensitive glucose sensor, bolus wizard, automatic alerts and a preset, threshold suspension feature. Because of those features, it is said to be helpful…
In November 2013, a study related to gestational diabetes appeared in The Endocrine Society’s publication, the Journal of Clinical Endocrinology and Metabolism. It was titled Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline. Upon its release, obstetricians undoubtedly started to question how they’ve been treating diabetic and pre-diabetic pregnant women for years. The study was actually designed to come up with best practices that physicians could use to treat diabetic women of child bearing age. It looked at pregnant women with a pre-existing type 1 or type 2 diabetes diagnosis as well as those who developed gestational diabetes. What the researchers found out during the study prompted them to recommend that obstetricians order specific diabetes testing during the initial prenatal visit as well as throughout the pregnancy. The diabetes testing methods that the researchers are calling for are the type that can detect very low blood glucose levels. The tests are considered the best course of action because of…
First Name Please enter first name
Last Name Please enter a last name
Phone Number Please enter a phone number
Email Invalid email
Please be assured that we value and protect your privacy. By submitting this information, I authorize Advanced Diabetes Supply to contact me.
  • brand
  • brand
  • brand
  • brand
  • brand
  • brand
  • brand
  • brand
  • brand
  • brand